Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Traditional Chinese medicine composition of treating ischemic cerebral apoplexy

A technology for ischemic cerebral apoplexy and composition, which can be applied in the directions of drug combination, drug delivery, and pharmaceutical formulation, and can solve the problems of impracticality and high risk.

Inactive Publication Date: 2013-09-18
梁怡芃
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although these treatment measures can achieve good results, they are only aimed at the acute attack stage of cerebral apoplexy, and only control and alleviate the deterioration of the disease. Although there are other treatment methods such as thrombus removal and surgery, the risk is relatively high. And it is not practical to make medicines that are affected by the time of onset, the age and constitution of the patient, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0118] Embodiment 1, formula:

[0119] Jujube 20g, saffron 20, amaranth 20g, cinnamon 20g, mulberry 20g, cassia seed 20g, frankincense 20g, viper 10g, arborvitae leaves 10g, bamboo leek 10g, radish 10g, bezoar 10g, centipede 30g, araceae 30g, fairy Lingpi 30g, Haitong 30g, ginseng flower 1g, light bamboo leaf 1g, red ginseng 1g, rose flower 1g, medlar 1g, sesame 1g, musk 0.1g;

[0120] The preparation method process of the present invention is:

[0121] Routinely sort the medicines according to the formula ratio → dry → pulverize to 300-400 mesh fine powder → mix evenly → pack into capsules.

[0122] Instructions: Take 2 capsules each time, twice a day, 0.25g per capsule, take with warm water.

Embodiment 2

[0123] Embodiment 2, formula:

[0124]Jujube 22g, saffron 22g, amaranth 22g, cinnamon 22g, mulberry 22g, cassia seed 22g, frankincense 22g, viper 12g, arborvitae leaves 12g, bamboo leek 12g, radish 12g, bezoar 12g, centipede 32g, araceae 32g, fairy Lingpi 32g, Haitong 32g, ginseng flower 2g, light bamboo leaf 2g, red ginseng 2g, rose flower 2g, medlar 2g, sesame 2g, musk 0.2g.

[0125] The preparation method is the same as in Example 1.

Embodiment 3

[0126] Embodiment 3, formula:

[0127] Jujube 25g, saffron 25g, amaranth 25g, cinnamon 25g, mulberry 25g, cassia seed 25g, frankincense 25g, viper 15g, arborvitae leaves 15g, bamboo leek 15g, radish 15g, bezoar 15g, centipede 35g, araceae 35g, fairy Lingpi 35g, Haitong 35g, ginseng flower 5g, light bamboo leaf 5g, red ginseng 5g, rose flower 5g, medlar 5g, sesame 5g, musk 0.5g.

[0128] The preparation method is the same as in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention aims at providing a traditional Chinese medicine composition of treating ischemic cerebral apoplexy. The traditional Chinese medicine composition is prepared by repeated verification of a clinical test, and accords with the principle of the traditional Chinese medicine. According to the formula, natural plant and animal drugs are selected as materials; the combined effect of each traditional Chinese medicine is utilized to treat the ischemic cerebral apoplexy; the traditional Chinese medicine composition is free of chemical preparation, free of poison and harm to a human body; no matter how serious the state of an illness is, the drugs of the traditional Chinese medicine composition can be independently taken, and do not need to be combined with other drugs, so as to achieve the cure target. The pesticide effect can lastingly play a role; recurrence is not easily generated; the treatment effect is good. The pharmaceutical composition is characterized by comprising the components of fructus choerospondiatis, saffron crocus, globe amaranth flower, cinnamon, mulberry, semen cassia, olibanum, long-noded pit viper, cacumen biotae, succus bambusae, raphanus sativus, calculus bovis, centipede, rhizoma arisaematis, herba epimedii, tomentose glorybower branchlet and leaf, ginseng flower, lophatherum gracile, red ginseng, rosa chinensis, fruit of Chinese wolfberry, sesame and musk according to the ratio of the formula by manners of sorting, baking, crushing into fine powder, evenly mixing and packaging into capsules.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating ischemic cerebral apoplexy. Background technique [0002] The blood that the human body supplies to the brain passes through large-diameter blood vessels to small-diameter blood vessels, and finally reaches capillaries. Therefore, when a large-caliber artery sclerosis occurs, the vessel wall can harden and thicken, and the lumen is full of sclerotic plaques and thrombus. The existence of these things may not cause clinical symptoms and are easily ignored by people. More tiny blood vessels will be blocked, causing cerebral infarction. [0003] Ischemic stroke can have the following stages according to the severity of the onset: [0004] Patients in the asymptomatic stage may have no neurological symptoms and signs, and lacunar cerebral infarctions are only found on CT or magnetic resonance (MRI) examinations. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/899A61K9/08A61K9/48A61P9/10A61K35/413A61K35/55A61K35/58A61K35/64A61K35/583A61K35/648
Inventor 梁怡芃
Owner 梁怡芃
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products